• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.36% Nasdaq Up 0.45%

    More On 009420.KS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    HanAll Biopharma Co., Ltd. (009420.KS)

    -KSE
    9,300.00 Down 1,600.00(14.68%) 2:00AM EDT
    Add to Portfolio
    Prev Close:10,900.00
    Open:9,640.00
    Bid:7,910.00
    Ask:7,920.00
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:9,300.00 - 10,150.00
    52wk Range:3,555.00 - 10,900.00
    Volume:42,217
    Avg Vol (3m):749,214
    Market Cap:373.96B
    P/E (ttm):N/A
    EPS (ttm):-320.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in KRW.

    Headlines

    • No Headlines available for 009420.KS at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.36
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    HanAll BioPharma Co., Ltd., a biopharmaceutical company, researches and develops biopharmaceutical products worldwide. It develops H176 and HL177, a series of anti-cancer agents for cancer metabolism; and HL156FIB, an EMT inhibitor for fibrotic di... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback